Inhibition of peripheral inflammatory disease by carbohydrate antigens derived from normal gut microbiota has been demonstrated for the GI tract, brain, peritoneum, and most recently the airway. We have demonstrated that polysaccharide A (PSA) from the commensal organism Bacteroides fragilis activates CD4 + T cells upon presentation by the class II major histocompatibility complex, and that these PSA-experienced T cells prevent the development of lung inflammation in murine models. While the PSA-responding T cells themselves are not canonical FoxP3 + regulatory T cells (Tregs), their ability to prevent inflammation is dependent upon the suppressive cytokine IL-10. Using an adoptive T cell transfer approach, we have discovered that PSAexperienced T cells require IL-10 expression by PSA-naïve recipient animals in order to prevent inflammation. A cooperative relationship was found between PSA-activated effector/memory T cells and tissue-resident FoxP3 + Tregs both in vivo and in vitro, and it is this cooperation that enables the suppressive activity of PSA outside of the gut environment where exposure takes place. These findings suggest that carbohydrate antigens from the normal microbiota communicate with peripheral tissues to maintain homeostasis through T cell-to-T cell cooperation.
Introduction
Over the last several decades, molecules derived from the normal gastrointestinal tract (GI) microbiota have been shown to play key roles in promoting overall health. This broad class of symbiosis factors collectively help to maintain immune homeostasis, strengthen border defenses, and exclude potentially harmful organisms. One such symbiosis factor family, collectively known as glycoantigens, are exemplified by the capsular polysaccharide PSA from the commensal gram-negative bacterium Bacteroides fragilis, which has shown a remarkable ability to quell a number of inflammatory conditions in rodent models (Tzianabos et al. 1995 (Tzianabos et al. , 1998 Holsti et al. 2004; Mazmanian et al. 2008; Ochoa-Reparaz et al. 2010; Johnson et al. 2015a ).
The documented decrease in inflammatory and autoimmune disease susceptibility which results from commensal microbial immunologic responses has largely been attributed to CD25 + FoxP3 + regulatory T cells (Tregs) (Rudensky 2011; Sakaguchi et al. 2013) . Although gut-associated FoxP3 − Tregs are well known (Battaglia et al. 2006) , the loss of functional FoxP3, whether through murine genetic manipulation or in the human disease called IPEX, results in severe autoimmune pathology . Thus, it is fair to say that FoxP3 + Tregs are critical for the establishment and maintenance of immune homeostasis throughout the body downstream of gut exposure to beneficial and commensal microbes. This leads to a widely accepted model in which gut antigens directly induce FoxP3 + Tregs, and that these responding cells are necessary for immune suppression mediated by canonical inhibitory cytokines like IL-10 and TGFβ. However, reports regarding PSA and the downstream gut-localized immune activation complicates this model. PSA is taken in by antigen presenting cells where it is processed to small fragments and presented at the cell surface via interactions with class II major histocompatibility complex (MHC), making it the first non-proteinaceous antigen to be presented by classical MHCII (Cobb et al. 2004 ) for activation and subsequent clonal expansion of CD4 + T cells (Johnson et al. 2015b) . T cell responses to PSA protect against abscess (Tzianabos et al. 1995 (Tzianabos et al. , 1998 and surgical adhesion formation (Holsti et al. 2004 ), several models of inflammatory bowel disease (IBD) (Mazmanian et al. 2008) , experimental autoimmune encephalomyelitis (EAE) (Ochoa-Reparaz et al. 2010) , and most recently airway inflammation (Johnson et al. 2015a) in an IL-10-dependent fashion. However, PSA-responding T cells have long been known to produce high concentrations of both IFNγ and IL-2 (Tzianabos et al. 1999) , characteristic of T helper-type I effector cells. We have also shown that depletion of FoxP3 + T cells in adoptive transfer experiments does not reduce the pulmonary inflammation protection afforded by these PSAexperienced T cells in naïve recipients (Johnson et al. 2015a) , which directly supports our human observations where PSA failed to induce any FoxP3 expression in responding T cells (Kreisman and Cobb 2011 ). These findings demonstrate that PSA expands a FoxP3 − T cell population in both murine and human systems, which can protect the lung environment through a mechanism that remains to be fully elucidated.
In this study, we employed an adoptive T cell transfer system using wild type and IL-10-deficient backgrounds to show that the IL-10 necessary for the prevention of pulmonary inflammation is not derived from the PSA-experienced T cells. Instead, we found that upon gut exposure to PSA, the responding donor T cells, characterized as being part of a FoxP3 
Results
IL-10 in PSA-experienced T cells is dispensable for protection against pulmonary inflammation IL-10 has been well established as the key suppressive cytokine downstream of exposure to PSA in humans (Kreisman and Cobb 2011) and in murine lung inflammatory models (Johnson et al. 2015a) . In order to determine the source of IL-10 in these systems, we orally gavaged PSA into mice carrying a targeted deletion of the IL-10 locus, harvested their IL-10-null (IL-10n) CD4 + T cells, adoptively transferred them into wild type (WT) PSA-naïve recipients, then induced airway inflammation using a traditional ovalbumin (OVA) model (Johnson et al. 2015a) . We reasoned that if PSA-expanded cells were directly responsible for suppression through the production of IL-10, then PSA-experienced IL-10n T cells should be unable to suppress inflammation. We found that despite lacking IL-10, PSA-experienced T cells from IL-10n mice were fully capable of preventing leukocyte infiltration into the airways, as measured by bronchoalveolar lavage fluid (BALF) cell differentials (Figure 1 ). Total white blood cells (WBC), neutrophils, lymphocytes and monocyte/macrophages were all indistinguishable (P >> 0.05) from the negative non-inflamed controls upon transfer of PSA-experienced but IL-10n CD4 + T cells.
Likewise, adoptive transfer of CD4 + T cells from saline-treated mice failed to show protection (Figure 1 ). Analysis of tissue pathology by both H&E staining and confocal imaging further revealed that PSA-experienced CD4 + T cells were able to prevent tissue inflammation and airway epithelial cell hyperplasia ( Figure 2 ). Confocal imaging also showed that the airway epithelial cells expressed myeloperoxidase (red; Figure 2 ), a hallmark of moderate to severe asthma, and that the PSA-experienced but IL10n T cells robustly prevented this upregulation despite their inability to release IL-10.
PSA-mediated inflammatory protection requires recipient-derived IL-10
Our previous studies conclusively demonstrated that in the complete absence of IL-10, PSA was incapable of preventing pulmonary inflammation in mice, and was ineffective at suppressive bystander T cell activation in human systems (Kreisman and Cobb 2011; Johnson et al. 2015a ); however, the results from our IL-10n transfer studies (Figures 1-2 ) suggest that either our previous findings were incorrect, or IL-10 is being made by a population other than the PSA-responding CD4 + T cells. In order to distinguish between these possibilities, we performed a reciprocal adoptive transfer experiment in which we gavage PSA into WT mice, and then adoptively transferred their PSA-experienced CD4 + T cell population into PSA-naïve IL-10n recipients. BALF differential analysis of the airways showed that the WT T cells were not capable of suppressing the OVAinduced lung inflammation in IL-10n recipients (Figure 3 ). In fact, saline and PSA-experienced T cells were indistinguishable from each other (P > 0.05), with both recipient mice showing significantly Fig. 1 . IL-10 in PSA-experienced T cells is dispensable for protection against airway leukocyte infiltration. IL-10-null (IL-10n) mice were exposed to PSA or saline via oral gavage. PSA-experienced CD4 + T cells were harvested, and 2 × 10 6 cells were adoptively transferred into OVA-sensitized WT recipients. On Day 7 of OVA or saline challenge, mice were sacrificed and lungs lavaged with saline. Recovered cells were analyzed by a Hemavet counter and plotted. PSA-experienced IL-10n CD4 + T cells were able to prevent leukocyte infiltration into the airways. * = P < 0.05; # = P > 0.05. P value calculated from Student's T-test. Error bars show mean with SEM.
increased WBCs, neutrophils, lymphocytes and monocyte/macrophages over negative controls (P < 0.05). Histological evaluation of these mice by H&E staining and confocal imaging further confirmed the inability of WT PSAexperienced T cells to suppress OVA-induced tissue inflammation, airway epithelial hyperplasia and epithelial myeloperoxidase expression ( Figure 4) . Indeed, the tissue inflammation is somewhat more severe compared to the reciprocal experiment (Figure 2 ), likely due to the lack of IL-10 in the recipient animals. These data confirm the requirement for IL-10 in PSA-mediated immune protection of the lung environment shown in our previous studies (Kreisman and Cobb 2011; Johnson et al. 2015a ), but also reveal that the IL-10 must be derived from cells in the recipient lung rather than from the PSA-responding CD4 + T cells themselves.
PSA-experienced T cells induce IL-10 in lung FoxP3
+ Tregs
Our findings suggest that PSA-experienced CD4 + T cells induce IL-10 in lung-resident cells of the recipient. Of the candidate cell populations well-documented to produce IL-10 in the lung, alveolar macrophages and FoxP3 + regulatory T cells are the most likely. In order to determine the source of IL-10, we gavaged IL-10n mice with PSA as before (Figure 1), and then adoptively transferred the PSA-experienced CD4 + T cells into IL-10-GFP reporter recipient mice in which GFP expression is controlled by the IL-10 promoter (IL-10f) (Kamanaka et al. 2006) . These mice were then subjected to the standard OVA-induced inflammatory model. Upon harvest, lungs were collected for flow cytometric analysis in order identify all IL-10 + (i.e., GFP + ) cells. We found that IL-10 expression was increased CD4
+ cells, but not CD4 -cells ( Figure 5A ). Adoptive transfer of PSA-experienced cells induced 10% of all CD4 + T cells in the lung to begin expressing IL-10 over background, and that the majority of that increase was accounted for by the FoxP3 + CD25
+ population ( Figure 5A ). The total number of IL-10 + CD4 + T cells in the lung increased by a factor of two in mice receiving PSAexperience IL-10n CD4 + T cells ( Figure 5B ), but no fluorescence over non-reporter WT macrophage fluorescence could be detected ( Figure 5C ). These data rule out alveolar macrophages and positively identify PSA-naïve FoxP3 + CD25 + Tregs as the IL-10-producing cells which are induced to release IL-10 upon adoptive transfer of PSA-experience CD4 + T cells.
PSA-experienced T effector cells induce IL-10 in FoxP3 + Tregs in vitro
We previously characterized the properties of PSA-responding T cells in both murine and human systems (Kreisman and Cobb 2011; Johnson et al. 2015a) . These studies showed these CD4 + T cells lack FoxP3, while expressing IL-10 and IFNγ with a CD45Rb low (Rb low ) surface phenotype, suggesting that they share characteristics of both gut-associated Tr1 regulatory T cells and traditional effector T cells. In Fig. 2 . IL-10 in PSA-experienced T cells is dispensable for protection against tissue inflammation. WT mice receiving 2 × 10 6 PSA-experienced IL-10n cells as described in Figure 1 were used to harvest lung tissue. Fixed and inflated lungs were sectioned and stained with H&E or EpCAM (green) and myeloperoxidase (red) antibodies. Animals receiving intranasal (i.n.) OVA challenges and saline exposed IL-10n T cells showed myeloperoxidase-positive leukocyte infiltration in and around the major airways, airway epithelial expression of myeloperoxidase and epithelial hyperplasia. PSA-experienced IL-10n T cells, in contrast, prevented these pathologies and returned tissue histology to that seen with saline (PBS) challenged mice. Fig. 3 . PSA-mediated inhibition of airway infiltration requires recipient-derived IL-10. WT mice were exposed to PSA or saline via oral gavage. PSA-experienced WT CD4 + T cells were harvested, and 2 × 10 6 cells were adoptively transferred into OVA-sensitized IL-10n recipients. On Day 7 of OVA or saline challenge, mice were sacrificed and lungs lavaged with saline. Recovered cells were analyzed by a Hemavet counter and plotted. PSA-experienced WT CD4 + T cells failed to prevent leukocyte infiltration into the airways. * = P < 0.05; # = P > 0.05. P value calculated from Student's T-test. Error bars show mean with SEM.
order to determine whether this subset is primarily responsible for the induction of IL-10 in FoxP3 + Tregs, we devised a 3 day in vitro co-culture assay. We cultured WT PSA-naïve Tregs, IL-10n PSA-experienced CD4 In addition, the IL-10 is being produced by the Tregs because these are the only cells in the system with a normal IL-10 allele, demonstrating the communication present between these cell subsets.
Since it is also established that PSA induces IFNγ in responding cells, placing them into an effector T cell category, we further determined whether PSA-experienced effector/memory T cells (Tem) cells could also induce Tregs to secret IL-10. Using the same approach as before, we found that when in co-culture with (Figure 7) . Moreover, tissue pathology by H&E and confocal microscopy confirmed the ability of Rb low but not Rb hi T cells to reduce tissue infiltration, epithelial hyperplasia and myeloperoxidase expression (Figure 8 ). This inhibitory activity was achieved using 6% of the total number of transferred cells (60,000) compared to the nondifferentiated CD4 + T cell transfers used in 
Discussion
IL-10 has become established as the primary mediator of suppression following exposure to PSA and/or its bacterial source B. fragilis. We have shown that IL-10 is necessary for PSA-activated T cell-mediated suppression in both human ex vivo assays (Kreisman and Cobb 2011 ) and in models of murine lung inflammation (Johnson et al. 2015a) , while others reported that IL-10 was critical in blocking inflammatory bowel disease (Mazmanian et al. 2008) The controversy in the field is not whether IL-10 is necessary for suppression, but the identity of the cells which produce it. Focusing upon the PSA-specific responding T cells, it is clear that PSA directly induces IL-10 production, but that the clonally expanded T cells do not express FoxP3 (Johnson et al. 2015a (Johnson et al. , 2015b . We have established this in murine (Johnson et al. 2015a ) and human T cells (Kreisman and Cobb 2011) , and it is supported by earlier findings which identified CD45Rb low cells as being the key population Figure 3 were used to harvest lung tissue. Fixed and inflated lungs were sectioned and stained with H&E or EpCAM (green) and myeloperoxidase (red) antibodies. Animals receiving intranasal (i.n.) OVA challenges and saline exposed WT T cells showed myeloperoxidase-positive leukocyte infiltration in and around the major airways, airway epithelial expression of myeloperoxidase and epithelial hyperplasia. Likewise, PSAexperienced WT T cells failed to prevent these pathologies and did not return tissue histology to that seen with saline (PBS) challenged mice. (Johnson et al. 2015a (Johnson et al. , 2015b . The observation that these cell subsets cooperate to generate protection through IL-10 is therefore fully consistent with all of the previously reported findings, including the requirement for IL-10. Perhaps more importantly, our results shed light upon how polysaccharide antigens, B. fragilis, and possibly other commensal organisms in the gut can influence distant tissues, including the lungs (Figure 9 ). It has always been assumed that T cells activated by commensal antigens simply travel to various tissues within the body and suppress unwanted inflammation. Yet, the data herein suggests that immune suppression is driven not only by the commensal antigens and their T cells, but also by the presence of FoxP3 + Tregs in the inflamed tissue and their activation state. Indeed, we found that the Tregs must be activated ( Figure 6A (Groux et al. 1997) , are also present and capable of controlling some inflammatory responses (Battaglia et al. 2006) . However, these cells lack the capacity to overcome the systemic autoimmunity resulting from the loss of FoxP3. It has been reported that some CD4 + FoxP3 − Tregs once expressed FoxP3 (Sujino et al. 2016 influence of the normal microbiota may be amplified and circulated throughout the body in times of inflammatory stress. mice, all on the C57B6 background, were purchased from the Jackson Laboratory (Bar Harbor, ME), C57B6. FoxP3-eGFP animals were a kind gift of Dr. Rudensky and Dr. Letterio. Mice were fed standard chow (Purina 5010) on a 12 h light/dark cycle in a specific pathogen free facility. Privacy provided in mating cages by "love shacks" (Bio Serv 53, . Mouse studies, and all animal housing at Case Western Reserve University were approved by and performed according to the guidelines established by the Institutional Animal Care and Use Committee of CWRU.
Materials and methods

Primary splenic T cells
Primary splenocytes were isolated from freshly harvested spleens, and reduced to a single cell suspension by passing them through a sterile 100 μM nylon mesh cell strainer (Fisher Scientific, Hampton, NH). For splenic T cell sorting, single cell suspension were labeled with anti-mouse CD4 magnetic microbeads, or alternatively negatively selected for CD4 and positively selected for CD25 by a mouse regulatory T cell isolation kit (Miltenyi Biotec, San Diego, CA), and separated with an autoMACS Pro Separator (Miltenyi Biotec, San Diego, CA), per manufacturer's instructions.
Pulmonary inflammation and adoptive transfer
Mice were sensitized to ovalbumin as previously reported (Johnson et al. 2015a) . Briefly, animals were challenged with intranasal ovalbumin (40 μg/dose) for 6 days before sacrifice on Day 7. For those animals adoptively receiving T cells, 2 × 10 6 CD4 + or 6 × 10 4 Rb low donor animal cells were recovered as described for primary splenic T cells and intravenously injected into recipients along with 2 × 10 6 CD4 + OT-II T cells 24 h prior to the start of challenge.
Animals receiving spent media were treated with 25 μL of media with each daily dose of OVA on Days 0-6. For murine PSA exposure, animals were orally gavaged with PSA as previously reported (Johnson et al. 2015a) . Animals were anesthetized with 3% isoflurane (Baxter) with an anesthesia system (VetEquip, Livermore, CA). Euthanasia, BALF recovery, and lung tissue preparation was performed as previously reported (Johnson et al. 2015a) . BALF automated differentials were acquired by a HemaVet 950 Hematology Analyzer.
Bacterial culture
Bacteroides fragilis expressing PSA only was a kind gift from Laurie Comstock (Harvard Medical School) and grown in batch culture for 24 h under anaerobic conditions. Anaerobiosis was maintained by nitrogen gas, and neutral pH was maintained by automated titration with 10 N NaOH. The basal medium contained 5 g yeast extract, 20 g proteose peptone, 5 g NaCl, 60 g glucose, 5 mg hemin and 0.5 mg vitamin K1 per liter.
PSA purification
The capsular complex from B. fragilis was isolated as previously described (Pantosti et al. 1991; Cobb et al. 2004) . Briefly, bacterial cell pellets were resuspended in a mixture of 1:1 water:phenol solution. The cells were then continuously mixed at 70°C with glass beads before decanting to remove beads and centrifugation to pellet debris. The aqueous phase was collected after centrifugation and then extracted with ethyl ether to remove residual phenol phase. The ethyl ether was removed from aqueous phase on a RotoVap (Buchi, New Castle, DE), and dialyzed against water overnight. The resulting sample was then digested with DNAse and RNAase (Worthington Biochemical, Lakewood, NJ) twice and then with Pronase (Calbiochem/EMD Millipore, Billerica, MA) twice, overnight for each. The digested sample was precipitated overnight in 80% ice cold ethanol. The solid was dried and resuspended in 3% deoxycholate. The sample was separated on a Sephacryl S-300 (GE Healthcare, Chicago, IL) column and 20 mL fractions collected. The presence of PSA and LPS was performed by SDS- 
Flow cytometry and cell sorting
For bronchoalveolar lavage fluid (BALF) cell analysis, pelleted cells were stained with anti-CD25-PE and anti-CD4-APC (eBioscience) or alternatively fixed/permeabilized by manufacturer's instructions (eBioscience, San Diego, CA) and stained with anti-CD25-APC and anti-FoxP3-PE (eBioscience, San Diego, CA) before analysis on a BD Accuri C6 flow cytometer (BD Biosciences, San Jose, CA). For splenic T cell sorting, positively selected CD4 + cells were stained with combinations of antibodies (0.5 μg/mL per) to CD62L-PE (BioLegend, San Diego, CA) or CD62L-BB515 (BD Bioscience), CD44-APC (BioLegend, San Diego, CA), CD45Rb-APC/Cy7 (BioLegend, San Diego, CA), and CD25-BV421 (BD Biosciences, Fig. 7 . PSA-experienced Rb low Tem cells protect mice from leukocyte airway infiltration. WT mice were exposed to PSA or saline via oral gavage.
PSA-experienced CD4 + T cells were harvested, sorted into Rb low Tem and Rb hi populations, and 6 × 10 4 cells were adoptively transferred into OVA-sensitized WT recipients. On Day 7 of OVA or saline challenge, mice were sacrificed and lungs lavaged with saline. Recovered cells were analyzed by a Hemavet counter and plotted. PSA-experienced Rb low but not Rb hi T cells were able to prevent leukocyte infiltration into the airways. * = P < 0.05; # = P > 0.05. P value calculated from Student's T-test. Error bars show mean with SEM. Fig. 8 . PSA-experienced Rb low Tem cells protect mice from tissue inflammation. WT mice receiving 6 × 10 4 PSA-experienced Rb low or Rb hi cells as described in Figure 7 were used to harvest lung tissue. Fixed and inflated lungs were sectioned and stained with H&E or EpCAM (green) and myeloperoxidase (red) antibodies. Animals receiving intranasal (i.n.) OVA challenges and saline exposed Rb hi T cells showed myeloperoxidase-positive leukocyte infiltration in and around the major airways, airway epithelial expression of myeloperoxidase, and epithelial hyperplasia. PSAexperienced Rb low T cells, in contrast, prevented these pathologies and returned tissue histology to that seen with saline (PBS) challenged mice. 
